A Clinical Study to Evaluate the TriKE COVID-19 Therapeutic in Humans
Latest Information Update: 25 Aug 2020
At a glance
- Drugs Coronavirus TriKE GT Biopharma (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- Sponsors GT Biopharma
- 25 Aug 2020 New trial record
- 20 Aug 2020 According to a GT Biopharma media release, the company is working to prepare TriKE COVID-19 for further preclinical testing and GMP manufacturing. The company is pleased with the progress Cytovance (contract development and manufacturing company ) is making, and is looking forward to being able to evaluate the TriKE COVID-19 therapeutic in humans.